SCHEMBL5069269

SCHEMBL5069269

Nc1nc(=O)[nH]cc1-c1cccs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.49
RAB9A P51151 1/20 0.49
ATM Q13315 1/20 0.49
ADORA2A P29274 4/20 0.42
ADORA1 P30542 4/20 0.42
PIM1 P11309 2/20 0.42
DHFR P00374 1/20 0.42
TDO2 P48775 1/20 0.41
CHEK1 O14757 1/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
CDK8 P49336 1/20 0.39
KDM4E B2RXH2 4/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5065139 0.74 IMPDH2 (0.48) CHEK1
SCHEMBL13312259 0.74 NPC1 (0.47) NPC1RAB9AATMADORA2AADORA1
SCHEMBL3485241 0.73 PARP1 (0.47) HSD17B10ALDH1A1HPGDKDM4EMAPT
SCHEMBL2495533 0.71 ALDH1A1 (0.53) NPC1RAB9APIM1CHEK1HSD17B10
SCHEMBL5064948 0.71 ADORA2A (0.40) ADORA2AADORA1PIM1CHEK1HSD17B10
SCHEMBL23931336 0.69 KDM4E (0.54) NPC1RAB9AATMADORA2AADORA1
SCHEMBL30124898 0.69 STK4 (0.61) NPC1RAB9AATMADORA2AADORA1
SCHEMBL20360672 0.68 TDO2 (0.52) NPC1RAB9AATMADORA2AADORA1
SCHEMBL4245392 0.68 KDM4E (0.55) NPC1RAB9AADORA2AHSD17B10CYP1A2
SCHEMBL14350065 0.68 NPC1 (0.53) NPC1RAB9AATMADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-10-23 US claimed
WO-2006076102-A2 FLUORESCENT NUCLEOSIDE ANALOGS THAT MIMIC NATURALLY OCCURRING NUCLEOSIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-07-20 WO claimed
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-10-23 US disclosed
WO-2006076102-A2 FLUORESCENT NUCLEOSIDE ANALOGS THAT MIMIC NATURALLY OCCURRING NUCLEOSIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides NSUN2, NSUN3, NCL NPC1 1433/4885RAB9A 4274/4885ATM 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.